LETTER TO THE EDITOR

You have free access to this content

In vitro studies of dasatinib, its targets and predictors of sensitivity

  1. Lucia B. Jilaveanu1,
  2. Christopher R. Zito1,
  3. Saadia A. Aziz1,
  4. Ashok Chakraborty1,
  5. Michael A. Davies2,
  6. Robert L. Camp3,
  7. David L. Rimm3,
  8. Arkadiusz Dudek4,
  9. Mario Sznol1,
  10. Harriet M. Kluger1

Article first published online: 10 MAR 2011

DOI: 10.1111/j.1755-148X.2011.00835.x

Issue

Pigment Cell & Melanoma Research

Pigment Cell & Melanoma Research

Volume 24, Issue 2, pages 386–389, April 2011

Additional Information

How to Cite

Jilaveanu, L. B., Zito, C. R., Aziz, S. A., Chakraborty, A., Davies, M. A., Camp, R. L., Rimm, D. L., Dudek, A., Sznol, M. and Kluger, H. M. (2011), In vitro studies of dasatinib, its targets and predictors of sensitivity. Pigment Cell & Melanoma Research, 24: 386–389. doi: 10.1111/j.1755-148X.2011.00835.x

Author Information

  1. 1

    Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USA

  2. 2

    Department of Melanoma Medical Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA

  3. 3

    Department of Pathology, Yale University School of Medicine, New Haven, CT, USA

  4. 4

    Masonic Cancer Center and Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA

*Harriet M. Kluger, e-mail: Harriet.Kluger@yale.edu

Publication History

  1. Issue published online: 10 MAR 2011
  2. Article first published online: 10 MAR 2011
  3. Accepted manuscript online: 15 FEB 2011 04:01AM EST

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS